
Medical researchers have identified immune biomarkers in HIV/TB patients before they begin ART that could help distinguish who goes on to develop IRIS or die after treatment.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/Ev0eG32C5p8/150209083049.htm